Labiotech.eu

News and Trends 29 Dec 2022

Watch: Zoetis looks for partnerships at BioFIT

Animal health company, Zoetis, has a pipeline of medicines, vaccines, diagnostics and technologies for livestock and pets. Active in more than 100 countries, Zoetis generated revenue of $7.8 billion in 2021, and has approximately 12,100 employees. The company recently announced a collaboration with the partners of the Pastoral Greenhouse Gas Research Consortium, and the New […]

December 29, 2022 - 1 minutemin - By Jim Cornall

News and Trends 23 Dec 2022

Watch: Eva Hoffmann talks about genetics and fertility

Eva R. Hoffmann is the Professor in Molecular Genetics at the Department of Cellular and Molecular Medicine at the University of Copenhagen in Denmark. She is involved in the Molecular Aging Program, Medical Genetics Program and the Centre for Chromosome Stability. Hoffmann’s laboratory investigates the role of the DNA damage response and cell cycle proteins in […]

December 23, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 23 Dec 2022

Watch: Something to SmiLe about in southern Sweden

SmiLe Incubator is a life science business incubator based in Medicon Village in Lund, Sweden. SmiLe helps entrepreneurs commercialize their ideas. There are currently 30 companies in the SmiLe Incubator that, together with alumni companies, have attracted more than €664 million ($705 million) in venture capital since 2014. SmiLe offers business coaching, a broad international […]

December 23, 2022 - 1 minutemin - By Jim Cornall

News and Trends 23 Dec 2022

Watch: The Medicon Valley Alliance celebrates 25th anniversary

The Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley. It covers eastern Denmark, which includes the capital, Copenhagen, as well as the southern Sweden region of Skåne, which includes Malmö and Lund. The organization includes more than 300 members, and encompasses universities, hospitals, human life science […]

December 23, 2022 - 1 minutemin - By Jim Cornall

News and Trends 23 Dec 2022

Affibody signs €20 million loan agreement

Affibody Medical AB has received a €20 million ($21.2 million) venture debt loan facility from the European Investment Bank, EIB, backed by the InvestEU program. The investment will support Affibody’s research and development activities in Europe of the next-generation biopharmaceuticals targeting unmet medical needs in the immunology and oncology fields. “We are very pleased and […]

December 23, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 23 Dec 2022

Beyond Biotech podcast 27: Cradle, Rani Therapeutics

This week, in our last podcast of 2022, we have two guests. We have conversations with Talat Imran, CEO of Rani Therapeutics; and Stef van Grieken, CEO and co-founder of Cradle. Rani Therapeutics – aiming to remove the pain of needles Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company focused on the oral delivery of […]

December 23, 2022

News and Trends 23 Dec 2022

Mersana Therapeutics and Merck to develop novel ADCs

Mersana Therapeutics, Inc. has announced a research collaboration and commercial license agreement with a subsidiary of Merck KGaA, Darmstadt, Germany to discover novel Immunosynthen antibody drug conjugates (ADCs) directed against up to two targets. Immunosynthen, Mersana Therapeutics’ proprietary STING-agonist ADC platform, is designed to generate systemically administered ADCs that locally activate STING signaling in both […]

December 23, 2022 - 3 minutesmins - By Jim Cornall

antibody drug conjugate adc small cancer treatment

News and Trends 23 Dec 2022

Merck and Kelun-Biotech collaborating on seven ADC cancer candidates

Merck (MSD outside of the U.S. and Canada), and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd), have entered into an exclusive license and collaboration agreement to develop seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer. “Advances in ADC technologies are yielding a new generation of candidates designed to more […]

December 23, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 23 Dec 2022

InSitu Biologics and Mayo Clinic to co-develop anti-cancer therapeutics

InSitu Biologics, Inc. has entered into an agreement with the Mayo Foundation for Medical Education and Research to further develop its prolonged-release drug delivery technology for anti-cancer therapeutics. The company has developed an industry-leading platform technology for loading large doses of a variety of medications into a localized delivery matrix. Once injected, medication elutes from […]

December 23, 2022 - 2 minutesmins - By Jim Cornall

In Depth 22 Dec 2022

10 biotech companies to watch in 2023

2022 is coming to an end. Here is a list of biotech companies from around the world that we are keeping in our sights in 2023. The year 2022 has seen a lot of uncertainty in biotech markets, resulting in tumbling or volatile stocks. A high number of biotech companies are even trading with market […]

December 22, 2022 - 9 minutesmins - By Jonathan Smith

News and Trends 22 Dec 2022

Watch: Norway’s Pre Diagnostics looks to early detection of Alzheimer’s

Pre Diagnostics AS is a new Norwegian company developing and commercializing an innovative and effective diagnostic test for Alzheimer’s disease (AD). Founded by an experienced biotech team, Pre Diagnostics owns the licensed rights to a patent-protected new diagnostic test from the Norwegian university hospital AHUS. The company said it will pursue cost-efficient product development with […]

December 22, 2022 - 1 minutemin - By Jim Cornall

News and Trends 22 Dec 2022

First CAR-T technology trial for patients with T-cell leukemia subtype authorized

The Spanish Agency of Medicines and Medical Products (AEMPS) has approved the CARxALL clinical trial led by the company OneChain Immunotherapeutics (OCI). It will be the world’s first trial with CAR-T technology for patients with a subtype of T-cell leukemia. The CARxALL trial will evaluate, for the first time, the CAR-T CD1a (OC-1) therapy. This […]

December 22, 2022 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Watch: Zoetis looks for partnerships at BioFIT

Watch: Eva Hoffmann talks about genetics and fertility

Watch: Something to SmiLe about in southern Sweden

Watch: The Medicon Valley Alliance celebrates 25th anniversary

Affibody signs €20 million loan agreement

Beyond Biotech podcast 27: Cradle, Rani Therapeutics

Mersana Therapeutics and Merck to develop novel ADCs

Merck and Kelun-Biotech collaborating on seven ADC cancer candidates

InSitu Biologics and Mayo Clinic to co-develop anti-cancer therapeutics

10 biotech companies to watch in 2023

Watch: Norway’s Pre Diagnostics looks to early detection of Alzheimer’s

First CAR-T technology trial for patients with T-cell leukemia subtype authorized

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!